Check Point Research published an analysis of SiliVaccine, an antivirus product developed in North Korea, offering a rare look into the country’s domestic security software ecosystem. The report examined the product’s internal design and functionality, highlighting how the software appears to combine conventional antivirus features with locally developed components and reflecting the isolated nature of North Korea’s technology environment.
The research provided defenders and intelligence teams with insight into how North Korean software is built, maintained, and positioned for internal use. By reverse engineering the product, Check Point documented technical characteristics that help illuminate the country’s broader cyber capability, supply chain independence efforts, and approach to endpoint protection within a tightly controlled national network.

TTPs, infrastructure, and targeting history in one profile.
1 event from the most recent confirmed update back to the earliest known activity.
Check Point Research published a report examining SiliVaccine, an antivirus product associated with North Korea, providing technical analysis of the software.
See this adversary's TTPs, infrastructure, and targeting history, correlated against your exposure.
1 reference tracked. Mallory keeps watching after this page renders.
Map indicators from this story to your assets and identify affected systems in minutes.
Every observed campaign, victim, and pivot linked to actors named in this story.
Malware, exploits, and IOCs connected to the activity described here.
YARA, Sigma, and Snort rules deployed to your SIEM as soon as they’re published.
Get matching new stories delivered to your team as they break — not the next morning.
Ask questions about this story and take action on the answers.